The association between daily 500 mg calcium supplementation and lower pregnancy-induced hypertension risk in Bangladesh

Abstract Background Evidence suggests that daily supplementation of 1500 to 2000 mg of calcium during pregnancy reduces pregnancy-induced hypertension (PIH). However, the evidence on the efficacy of low-dose calcium supplementation on PIH is limited. This paper assesses the longitudinal correlation...

Full description

Bibliographic Details
Main Authors: Fouzia Khanam, Belal Hossain, Sabuj Kanti Mistry, Dipak K. Mitra, Wameq Azfar Raza, Mahfuza Rifat, Kaosar Afsana, Mahfuzar Rahman
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Pregnancy and Childbirth
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12884-018-2046-0
id doaj-1843832c6a1340f3809509f396a05613
record_format Article
spelling doaj-1843832c6a1340f3809509f396a056132020-11-25T02:49:25ZengBMCBMC Pregnancy and Childbirth1471-23932018-10-011811910.1186/s12884-018-2046-0The association between daily 500 mg calcium supplementation and lower pregnancy-induced hypertension risk in BangladeshFouzia Khanam0Belal Hossain1Sabuj Kanti Mistry2Dipak K. Mitra3Wameq Azfar Raza4Mahfuza Rifat5Kaosar Afsana6Mahfuzar Rahman7Research and Evaluation Division, BRAC CenterResearch and Evaluation Division, BRAC CenterResearch and Evaluation Division, BRAC CenterDepartment of Public Health, North South UniversityPoverty and Equity, The World BankHealth, Nutrition and Population Program, BRAC CenterHealth, Nutrition and Population Program, BRAC CenterResearch and Evaluation Division, BRAC CenterAbstract Background Evidence suggests that daily supplementation of 1500 to 2000 mg of calcium during pregnancy reduces pregnancy-induced hypertension (PIH). However, the evidence on the efficacy of low-dose calcium supplementation on PIH is limited. This paper assesses the longitudinal correlation between low-dose calcium intake (500 mg daily) and change in blood pressure during pregnancy among a homogeneous population in terms of hypertension and pre-eclampsia. Methods The study followed a retrospective cohort study design, and was carried out among 11,387 pregnant women from 10 rural upazilas (sub-districts) of Bangladesh where maternal nutrition initiative (MNI), implemented by Building Resources Across Communities (BRAC), was ongoing. The modified Poisson regression model was used to estimate the association (risk ratio) between consumption of calcium tablets and PIH. Results The present research found that women who consumed 500 mg/d calcium tablets for more than 6 months during their pregnancy had a 45% lower risk of developing hypertension compared to those who consumed less calcium (RR = 0.55, 95% CI = 0.33–0.93). Conclusions Daily supplementation of 500 mg oral calcium during pregnancy for at least 180 tablets is associated with a considerably reduced risk of PIH, but this study is unable to confirm whether this association is causal. The causal relationship needs to be confirmed through a large scale randomized controlled trial.http://link.springer.com/article/10.1186/s12884-018-2046-0Pregnancy-induced hypertensionCalcium supplementationMaternal nutrition initiative (MNI)Global healthMaternal mortality
collection DOAJ
language English
format Article
sources DOAJ
author Fouzia Khanam
Belal Hossain
Sabuj Kanti Mistry
Dipak K. Mitra
Wameq Azfar Raza
Mahfuza Rifat
Kaosar Afsana
Mahfuzar Rahman
spellingShingle Fouzia Khanam
Belal Hossain
Sabuj Kanti Mistry
Dipak K. Mitra
Wameq Azfar Raza
Mahfuza Rifat
Kaosar Afsana
Mahfuzar Rahman
The association between daily 500 mg calcium supplementation and lower pregnancy-induced hypertension risk in Bangladesh
BMC Pregnancy and Childbirth
Pregnancy-induced hypertension
Calcium supplementation
Maternal nutrition initiative (MNI)
Global health
Maternal mortality
author_facet Fouzia Khanam
Belal Hossain
Sabuj Kanti Mistry
Dipak K. Mitra
Wameq Azfar Raza
Mahfuza Rifat
Kaosar Afsana
Mahfuzar Rahman
author_sort Fouzia Khanam
title The association between daily 500 mg calcium supplementation and lower pregnancy-induced hypertension risk in Bangladesh
title_short The association between daily 500 mg calcium supplementation and lower pregnancy-induced hypertension risk in Bangladesh
title_full The association between daily 500 mg calcium supplementation and lower pregnancy-induced hypertension risk in Bangladesh
title_fullStr The association between daily 500 mg calcium supplementation and lower pregnancy-induced hypertension risk in Bangladesh
title_full_unstemmed The association between daily 500 mg calcium supplementation and lower pregnancy-induced hypertension risk in Bangladesh
title_sort association between daily 500 mg calcium supplementation and lower pregnancy-induced hypertension risk in bangladesh
publisher BMC
series BMC Pregnancy and Childbirth
issn 1471-2393
publishDate 2018-10-01
description Abstract Background Evidence suggests that daily supplementation of 1500 to 2000 mg of calcium during pregnancy reduces pregnancy-induced hypertension (PIH). However, the evidence on the efficacy of low-dose calcium supplementation on PIH is limited. This paper assesses the longitudinal correlation between low-dose calcium intake (500 mg daily) and change in blood pressure during pregnancy among a homogeneous population in terms of hypertension and pre-eclampsia. Methods The study followed a retrospective cohort study design, and was carried out among 11,387 pregnant women from 10 rural upazilas (sub-districts) of Bangladesh where maternal nutrition initiative (MNI), implemented by Building Resources Across Communities (BRAC), was ongoing. The modified Poisson regression model was used to estimate the association (risk ratio) between consumption of calcium tablets and PIH. Results The present research found that women who consumed 500 mg/d calcium tablets for more than 6 months during their pregnancy had a 45% lower risk of developing hypertension compared to those who consumed less calcium (RR = 0.55, 95% CI = 0.33–0.93). Conclusions Daily supplementation of 500 mg oral calcium during pregnancy for at least 180 tablets is associated with a considerably reduced risk of PIH, but this study is unable to confirm whether this association is causal. The causal relationship needs to be confirmed through a large scale randomized controlled trial.
topic Pregnancy-induced hypertension
Calcium supplementation
Maternal nutrition initiative (MNI)
Global health
Maternal mortality
url http://link.springer.com/article/10.1186/s12884-018-2046-0
work_keys_str_mv AT fouziakhanam theassociationbetweendaily500mgcalciumsupplementationandlowerpregnancyinducedhypertensionriskinbangladesh
AT belalhossain theassociationbetweendaily500mgcalciumsupplementationandlowerpregnancyinducedhypertensionriskinbangladesh
AT sabujkantimistry theassociationbetweendaily500mgcalciumsupplementationandlowerpregnancyinducedhypertensionriskinbangladesh
AT dipakkmitra theassociationbetweendaily500mgcalciumsupplementationandlowerpregnancyinducedhypertensionriskinbangladesh
AT wameqazfarraza theassociationbetweendaily500mgcalciumsupplementationandlowerpregnancyinducedhypertensionriskinbangladesh
AT mahfuzarifat theassociationbetweendaily500mgcalciumsupplementationandlowerpregnancyinducedhypertensionriskinbangladesh
AT kaosarafsana theassociationbetweendaily500mgcalciumsupplementationandlowerpregnancyinducedhypertensionriskinbangladesh
AT mahfuzarrahman theassociationbetweendaily500mgcalciumsupplementationandlowerpregnancyinducedhypertensionriskinbangladesh
AT fouziakhanam associationbetweendaily500mgcalciumsupplementationandlowerpregnancyinducedhypertensionriskinbangladesh
AT belalhossain associationbetweendaily500mgcalciumsupplementationandlowerpregnancyinducedhypertensionriskinbangladesh
AT sabujkantimistry associationbetweendaily500mgcalciumsupplementationandlowerpregnancyinducedhypertensionriskinbangladesh
AT dipakkmitra associationbetweendaily500mgcalciumsupplementationandlowerpregnancyinducedhypertensionriskinbangladesh
AT wameqazfarraza associationbetweendaily500mgcalciumsupplementationandlowerpregnancyinducedhypertensionriskinbangladesh
AT mahfuzarifat associationbetweendaily500mgcalciumsupplementationandlowerpregnancyinducedhypertensionriskinbangladesh
AT kaosarafsana associationbetweendaily500mgcalciumsupplementationandlowerpregnancyinducedhypertensionriskinbangladesh
AT mahfuzarrahman associationbetweendaily500mgcalciumsupplementationandlowerpregnancyinducedhypertensionriskinbangladesh
_version_ 1724743596980043776